Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients
暂无分享,去创建一个
[1] E. Kaluski,et al. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea , 2018, European heart journal.
[2] J. Concato,et al. Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea , 2017, Thorax.
[3] I. Elgendy,et al. Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea. , 2017, The American journal of cardiology.
[4] S. Yin,et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment , 2017, Sleep and Breathing.
[5] A. Pack,et al. Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. , 2017, Journal of the American College of Cardiology.
[6] J. Herlitz,et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. , 2016, American journal of respiratory and critical care medicine.
[7] Rui Chen,et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. , 2016, The New England journal of medicine.
[8] M. Martínez-García,et al. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. , 2014, American journal of respiratory and critical care medicine.
[9] M. Mosteiro,et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. , 2013, JAMA.
[10] J. Montserrat,et al. Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial , 2013 .
[11] T. Young,et al. Increased prevalence of sleep-disordered breathing in adults. , 2013, American journal of epidemiology.
[12] J. Montserrat,et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. , 2012, American journal of respiratory and critical care medicine.
[13] Gilles Barone-Rochette,et al. Mechanisms of cardiac dysfunction in obstructive sleep apnea , 2012, Nature Reviews Cardiology.
[14] J. Montserrat,et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. , 2012, JAMA.
[15] A. Lurie. Cardiovascular disorders associated with obstructive sleep apnea. , 2011, Advances in cardiology.
[16] T. Young,et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.
[17] L. Bortolotto,et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. , 2007, American journal of respiratory and critical care medicine.
[18] K. Reynolds,et al. Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2007, Hypertension.
[19] W. McNicholas,et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. , 2005, Chest.
[20] Jose M Marin,et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.
[21] G. Jondeau,et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. , 2004, European heart journal.
[22] Adelaide M. Arruda-Olson,et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.
[23] Daniel J Buysse,et al. Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research , 2000 .
[24] Daniel J Buysse,et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.
[25] O. Gureje,et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care , 1997, Psychological Medicine.
[26] J. Leech,et al. Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. , 1992, Chest.
[27] M. Johns,et al. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.
[28] L. Findley,et al. Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. , 1985, Chest.
[29] B. Phillips. Long-term Cardiovascular Outcomes in Men With Obstructive Sleep Apnoea-Hypopnoea With or Without Treatment With Continuous Positive Airway Pressure: An Observational Study , 2007 .